STEELE GLENN JR MD PHD bought PTCT
January 2, 2026 · Form 4 insider transaction
STEELE GLENN JR MD PHD bought 12,000 shares of PTC Therapeutics, Inc. at $30.86 per share, a transaction worth $370.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,000
Price
$30.86
Total value
$370.3K
InsiderSTEELE GLENN JR MD PHD
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after30,500
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 8, 2025.